Preview Mode Links will not work in preview mode

Join host Paul Shapiro as he talks with some of the leading start-up entrepreneurs and titans of industry alike using their businesses to help solve the world’s most pressing problems.

Nov 15, 2024

Eric Schulze loves the intersection of science and food so much that after many years as an FDA regulator, he decided in 2016 to leave the federal government to join the then-nascent Memphis Meats (now UPSIDE Foods). He’d go on to spend the next seven years working to advance the cultivated meat pioneer’s science, technology, communications, and ultimate regulatory approval by the agency for which he used to work.

Now, Eric’s charting a new path for himself, founding GoodHumans, a consultancy aimed at assisting and even launching biotech startups seeking to bring their new innovations to the world.

In this episode, Eric and I discuss the state of the cultivated meat movement today and where it may be heading. This includes the path to commercialization, the obituaries being written for the sector, the statewide sales bans on the product, and comparisons to other technologies. We even discuss our mutual love of sci-fi and give some recommendations to those of you fellow nerds out there. 

Eric’s a wealth of knowledge on all things alt-protein, so if you want both information and inspiration, listen to what he’s got to say.

Discussed in this episode

More about Eric Schulze, PhD

Eric Schulze, PhD is a professional molecular biologist, genetic engineer, and former federal biotechnology regulator, and most recently is the CEO of GoodHumans, a full-service strategy and design firm. He served as Vice President of Product and Regulation at UPSIDE Foods, where he led both design and development of the company’s meat products as well as its regulatory-, policy-, and government affairs. Before that, he served as a U.S. Food and Drug Administration regulator, handling a portfolio of novel food and drug biotechnology products. As a civil servant, Dr. Schulze also served as a federal STEM education policy capacity within the National Science Foundation and currently works with the National Academy of Sciences on undergraduate STEM education transformation. He holds a doctorate in genetic, cellular, and molecular biology with a specialty in embryonic stem cell engineering and is trained in broadcast communication, speechwriting, and risk assessment.